Anja König
InvestorGlobal Head of the Novartis Venture Fund at Novartis Venture Fund
Basel, Switzerland
Find your path to Anja
345 people in our graph share verified history with Anja — schools, employers, funds. One of them is your warm intro.
Mike ZakunlockedAnja: together at Cornell (1995–2000)
×7Anja: together at Cornell
Anja: together at Sensirion
×2Anja: together at Mediar Therapeutics
About
Anja Koenig, who holds a PhD in Physics from Cornell University, leads the Novartis Venture Fund and was previously a Managing Director at the fund covering Switzerland, the UK, the rest of Europe, and Asia/Pacific. Before joining NVF, she was an Associate Partner at McKinsey and Company in New York, working with healthcare companies across the US, Europe, and emerging markets. She is involved in the Swiss startup ecosystem and serves on the board of Sensirion, a publicly listed Swiss engineering company.
Contact· self-published, not guessed
Invests in
BiotechHealthtech
Experience
- NovartisGlobal Head Novartis Venture Fundcurrent2017 — presentBasel, Basel, Switzerland
- NovartisManaging Director Novartis Venture Fund2007 — 2017
- NovartisStrategic Assistant to Chairman and CEO2006 — 2007Basel, Basel, Switzerland
- SensirionIndependent Board Director (Verwaltungsrat)current2021 — presentZürich Metropolitan Area
- InnosuisseDirector Board of Directorscurrent2025 — presentSwitzerland
- Mediar TherapeuticsBoard Director2023 — 2025Boston, Massachusetts, United States
- SNSF Swiss National Science FoundationMember of the Board of Trustees (Stiftungsrat and Stiftungsratsausschuss)2021 — 2024Berne, Switzerland
- Forendo Pharma LtdBoard Director2014 — 2021Turku, Southwest Finland, Finland
- ArctosBoard Director2020 — 2021Basel, Switzerland
- Ribon TherapeuticsBoard Director2019 — 2021Greater Boston
- ETH ZürichInvestment Committee Member2019 — 2021Zurich, Switzerland
- University of ZurichBoard Director of UZH Life Sciences Fund2017 — 2020
- BRIDGE Programm (SNSF-Innosuisse)Steering Committee Member and POC Jury2018 — 2019Bern Area, Switzerland
- Bicycle TherapeuticsBoard Director2009 — 2019Cambridge, United Kingdom
- ANAVEON AGBoard Director2018 — 2019Basel, Switzerland
- BaseLaunchJury member2016 — 2018Basel, Basel, Switzerland
- Cutiss AGBoard director2017 — 2018Zurich, Switzerland
- F2GBoard director2011 — 2018Manchester Area, United Kingdom
- Sosei HeptaresBoard Director2009 — 2015London, Greater London, United Kingdom
- Covagen AGBoard Director2007 — 2014Zurich, Switzerland
- Nabriva Therapeutics plcBoard Director2008 — 2013Vienna, Vienna, Austria
- MerLion Pharmaceuticals Pte LtdBoard director2007 — 2009Singapore
Skills & more
Board of DirectorsVenture Capital52Biotechnology23Life Sciences5Technology Transfer5Pharmaceutical Industry4Mergers & Acquisitions17M&A experience2Medical Devices7Strategy5Lifesciences5Start-ups5
+11 more
Corporate DevelopmentDue DiligenceCommercializationManagement ConsultingCross-functional Team LeadershipClinical DevelopmentStrategic PlanningDrug DevelopmentResearch and Development (R&D)Financial ModelingBiopharmaceuticalsFrom Anja's professional profile.
Investments
Board seats
Sensirion
Investor
Arctos Medical AGBicycle TherapeuticsCovagen AGForendo PharmaGenedataHeptares Therapeutics, LtdNabriva TherapeuticsPharmAbcineQurient Therapeutics
Per the firm's website.
Colleagues at Novartis Venture Fund
Adam Cotton
Principal at Novartis Venture Fund
Anís
Head of Scoping, Pharma at Deep Science Ventures
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund
Elena Battistello
Analyst at Novartis Venture Fund
Frequently asked questions
- Who is Anja König?
- Anja Koenig, who holds a PhD in Physics from Cornell University, leads the Novartis Venture Fund and was previously a Managing Director at the fund covering Switzerland, the UK, the rest of Europe, and Asia/Pacific. Before joining NVF, she was an Associate Partner at McKinsey and Company in New York, working with healthcare companies across the US, Europe, and emerging markets. She is involved in the Swiss startup ecosystem and serves on the board of Sensirion, a publicly listed Swiss engineering company.
- Where does Anja König work?
- Anja König is Global Head of the Novartis Venture Fund at Novartis Venture Fund.
- What does Anja König invest in?
- Anja König invests in Biotech, Healthtech.
- What boards does Anja König sit on?
- Anja König holds tracked board seats at Sensirion.
- What companies has Anja König invested in?
- Investments tracked here include Arctos Medical AG, Bicycle Therapeutics, Covagen AG, Forendo Pharma, Genedata, Heptares Therapeutics, Ltd, Nabriva Therapeutics, PharmAbcine, Qurient Therapeutics.
- Where did Anja König go to school?
- Anja König studied at Cornell University (PhD, Physics); Ludwig-Maximilians-Universität München (Masters (Diplom), Physics); University of Oxford (Physics).
Same school
Also attended Cornell University1,165
Jenny LeeSenior Managing Partner at Granite AsiaNeeraj AgrawalGeneral Partner at Battery VenturesJohn ZimmerCo-founder of LyftMichelle FernandesInvestor at Index VenturesMike ZakInvestor at CRV (Charles River Ventures)Micah RosenbloomGeneral Partner at Founder Collective
+ 1,159 more
Also attended Ludwig-Maximilians-Universität München220
Julia SchrameierAssociate at Manta Ray VenturesCeline XiaoInvestor at DN CapitalFriedrich von WulffenPrincipal at Burda Principal InvestmentsElçinTalent Team at Hummingbird VenturesLaura WeigertSenior Associate at Marlin Equity PartnersToby TriebelPartner at FinTech Collective
+ 214 more
Also attended University of Oxford1,552
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 1,546 more
Shared employers
Also worked at Innosuisse17
Martin ScherrerPartner & Head of Managed Funds at RedstoneAnja KoenigGlobal Head of NVF at Novartis Venture FundReinhard VoelkelInvestor at Sand Hill AngelsOliver WalkerManaging Partner at CGS Management AGMichael WackerManaging Partner at BioMedPartnersAndreas JurgeitPartner at Gimv
%20(4).avif)
+ 11 more
